Cargando…

Synthesis, Quality Control and Stability Studies of 2-[(18)F]Fluoro-2-Deoxy-D-Glucose((18)F-FDG) at Different Conditions of Temperature by Physicochemical and Microbiological Assays

The introduction of 2-[(18)F] fluor-2-deoxy-D-glucose ((18)FDG) has provided a valuable tool for the study of glucose metabolism in both normal and diseased tissue in conjunction with positron emission tomography (PET). (18)FDG is the most important radiopharmaceutical to be used in Nuclear Medicine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahmani, Siyavash, Shahhoseini, Soraya, Mohamadi, Reza, Vojdani, Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603868/ https://www.ncbi.nlm.nih.gov/pubmed/28979313

Ejemplares similares

Ferret Thoracic Anatomy by 2-Deoxy-2-(18F)Fluoro-D-Glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging
por: Wu, Albert, et al.
Publicado: (2012)

Using 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) to study carbon allocation in plants after herbivore attack
por: Meldau, Stefan, et al.
Publicado: (2015)

TMSOTf assisted synthesis of 2’-deoxy-2’-[(18)F]fluoro-β-D-arabinofuranosylcytosine ([(18)F]FAC)
por: Gangangari, Kishore K., et al.
Publicado: (2018)

Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
por: Wang, Fu-Li, et al.
Publicado: (2016)

Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[(18)F]fluoro-d-glucose (FDG) and 3′-[(18)F]fluoro-3′-deoxythymidine (FLT)
por: Molthoff, Carla F. M., et al.
Publicado: (2007)

Radiotherapeutic use of 2-deoxy-2-[(18)F]fluoro-D-glucose – a comment
por: Meyer, Michael Andrew
Publicado: (2004)

[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010)

(18)F-fluoro-2-deoxy-D-glucose positron emission tomography findings of neurolymphomatosis
por: Jung, Yun Hwa, et al.
Publicado: (2014)

Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
por: Mirzaei, Siroos, et al.
Publicado: (2003)

Effect of duration of fasting and diet on the myocardial uptake of F-18-2-fluoro-2-deoxyglucose (F-18 FDG) at rest
por: Kumar, Pankaj, et al.
Publicado: (2014)

Importance of diffuse versus focal F-18 fluoro-deoxy-glucose uptake in oesophagus
por: Santhosh, Sampath, et al.
Publicado: (2011)

Positron emitting (18)F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy
por: Mortimer, Joanne E, et al.
Publicado: (2003)

Practical Consideration Regarding Stability of F-18 2-Deoxy-2-[(18)F] Fluoro-D-Glucose, Procured from a Distant Commercial Production Site
por: Vatsa, Rakhee, et al.
Publicado: (2020)

Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET
por: Yoshida, Yoshio, et al.
Publicado: (2009)

Chemotherapy-induced modulation of [(18)F]Fluoro-2-deoxy-D-glucose incorporation at the tumour cell level
por: Sharma, RI, et al.
Publicado: (2008)

Unexpected -[18F] fluoro-2-deoxy-D-glucose accumulation in subarachnoid hemorrhage due to an aneurysm rupture
por: Tokue, Hiroyuki, et al.
Publicado: (2021)

Optimal 2-[(18)F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
por: Horsager, Jacob, et al.
Publicado: (2016)

2-deoxy-2[(18)F]fluoro-D-glucose positron emission tomography–computed tomography in rheumatological diseases
por: Subesinghe, Manil, et al.
Publicado: (2021)

Evaluation of Shoulder Disorders by 2-[F-18]-fluoro-2-deoxy-D-glucose Positron Emission Tomography and Computed Tomography
por: Moon, Young Lae, et al.
Publicado: (2010)

Appearance of Adrenal Myelolipomas on 2-deoxy-2-((18)F) fluoro-D-glucose Positron Emission Tomography-Computed Tomography
por: Rowe, Steven P., et al.
Publicado: (2017)

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
por: Plöckinger, U., et al.
Publicado: (2018)

Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[(18)F]-Fluoro-L-Thymidine ([(18)F]FLT) Positron Emission Tomography (PET)
por: Ullrich, Roland T., et al.
Publicado: (2008)

F-18 fluoro-deoxy-glucose and F-18 sodium fluoride cocktail PET/CT scan in patients with breast cancer having equivocal bone SPECT/CT
por: Harisankar, Chidambaram Natrajan Balasubramanian, et al.
Publicado: (2014)

Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children
por: Kim, Ji Eun, et al.
Publicado: (2014)

Myxoid liposarcoma with negative features on bone scan and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography
por: Sakamoto, Akio, et al.
Publicado: (2012)

Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
por: Seiler, Stefanie M. F., et al.
Publicado: (2015)

All That Glitters Is Not Gold" - A Case of an Occult Foreign Body in the Lung with Elevated 2-[18F]-Fluoro-2-deoxy-D-glucose (FDG) Uptake Mimicking Bronchogenic Carcinoma
por: Kanchustambham, Venkatkiran, et al.
Publicado: (2017)

18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol
por: Jena, Rahul, et al.
Publicado: (2023)

2-Deoxy-2[F-18]FDG-PET for Detection of Recurrent Laryngeal Carcinoma after Radiotherapy: Interobserver Variability in Reporting
por: van der Putten, L., et al.
Publicado: (2008)

(18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis
por: McKenney-Drake, Mikaela L., et al.
Publicado: (2018)

Evaluation of (18)F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy
por: Shoda, H, et al.
Publicado: (2007)

2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis
por: Elzinga, E. H., et al.
Publicado: (2007)

Positron emission tomography agent 2-deoxy-2-[(18)F]fluoro-D-glucose has a therapeutic potential in breast cancer
por: Moadel, Renee M, et al.
Publicado: (2003)

18F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography: Computed Tomography for Preoperative Staging in Gastric Cancer Patients
por: Youn, Seok Hwa, et al.
Publicado: (2012)

Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission and computed tomography
por: Esmail, H, et al.
Publicado: (2016)

Paclitaxel-induced dermal hypersensitivity lesions: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography
por: Biner, Inci Uslu, et al.
Publicado: (2018)

Metabolic liver function in humans measured by 2-(18)F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential
por: Bak-Fredslund, Kirstine P., et al.
Publicado: (2017)

Role of brain 2-[(18)F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis
por: Canosa, Antonio, et al.
Publicado: (2022)

Background Colonic (18)F-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography Is Associated with the Presence of Colorectal Adenoma
por: Lee, Ko Eun, et al.
Publicado: (2016)

Characteristics of Physiological (18)F-Fluoro-2-Deoxy-D-Glucose Uptake and Comparison Between Cats and Dogs With Positron Emission Tomography
por: Chae, Yeon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jdscdgju555sfufih7arnhrjrg